Exercise may improve quality of life for kidney cancer patients
A recent study presented by the Australia and New Zealand [...]
Cancer waiting times: latest updates
Over the past few years, there has been extreme pressure [...]
WECAN Academy 2024
Mid July, one of the Action Kidney Cancer team, Steve [...]
FDA grant fast track status to CAR T cell therapy for kidney cancer
The Food and Drug Administration (FDA) in America has granted [...]
Perioperative nivolumab in intermediate/high risk kidney cancer patients
The standard of care for patients with intermediate/high risk kidney [...]
Why the next UK Government must set out a new strategy for cancer
With an election weeks away, political parties have the opportunity [...]
Patient perspectives on immunotherapy dosing schedules
Immunotherapy (in particular immune checkpoint inhibitors) has transformed the treatment [...]
ASCO 2024: Treatment-free survival with cabozantinib plus nivolumab
At the American Society of Clinical Oncology Annual Meeting (ASCO) last [...]
Summary of kidney cancer highlights from ASCO 2024
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting [...]
Stereotactic radiotherapy plus immunotherapy for brain metastases
Stereotactic radiosurgery (SRS) is a procedure that uses special equipment [...]
